Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis by Al-Fayoumi S, Hashiguchi T, Shirakata Y, Mascarenhas J, Singer JW

Get full text

Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis by Harrison, C, Yacoub, A, Scott, B, Mead, A, Gerds, AT, Kiladjian, J-J, Mesa, R, Egyed, M, Scheid, C, Gutierrez, VG, O'Sullivan, J, Buckley, S, Kanellopoulos, K, Mascarenhas, J

Ruxolitinib therapy followed by reduced-intensity conditioning for hematopoietic cell transplantation for myelofibrosis: Myeloproliferative Disorders Research Consortium 114 study by Gupta, V, Kosiorek, H, Mead, A, Klisovic, R, Galvin, J, Berenzon, D, Yacoub, A, Viswabandya, A, Mesa, R, Goldberg, J, Price, L, Salama, M, Weinberg, R, Rampal, R, Farnoud, N, Dueck, A, Mascarenhas, J, Hoffman, R